SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study.

Alexandra Dopfer-JablonkaSandra SteffensFrank MüllerMarie MikuteitJacqueline NiewolikAnne CossmannMetodi V StankovGeorg M N BehrensEva HummersGloria HeesenDominik SchröderSascha RoderFrank KlawonnKai VahldiekJustin HasenkampJonathan KalluskyChristine S FalkTobias R OverbeckStephanie Heinemann

Published in: BMC infectious diseases (2022)

This study was registered with German Clinical Trial Registry (registration number: DRKS00023972) on 30th December 2020.

Keyphrases

clinical trial
sars cov
study protocol
immune response
randomized controlled trial
dna damage
cell cycle
phase ii
community dwelling
placebo controlled